Kommende Woche bin ich auf der #BiblioCon26 und gebe Einblicke in die nationale Roadmap zur Nutzung und Verbreitung von Persistenten Identifikatoren #PIDs in Deutschland.
Aktuell ist die Roadmap in einer öffentlichen Kommentierungsphase
👉 https://tinyurl.com/bdhjtxhz
📆 Do, 21. Mai, 11:00 – 12:30
📍 Raum V / 5
👀 Persistente Identifikatoren als Fundament unserer Wissenslandschaft: Die PID-Roadmap für Deutschland
#BiblioCON #FAIR #FDM @bibliocon #OpenScience #PIDNetwork @paul4kant @AntoniaS
Die Roadmap enthält Empfehlungen zur Weiterentwicklung einer vernetzten, nachhaltigen PID-Landschaft in Deutschland – von lokalen Anwendungen bis hin zu systemischen Effekten einer breiten Nutzung.
Jetzt sind eure Perspektiven gefragt: Welche Empfehlungen sind besonders relevant? Wo gibt es Lücken oder Ergänzungsbedarf?
📅 Kommentierung bis 10. Juni 2026
✏️ https://docspace-s7k23k.onlyoffice.com/s/rXdFTjPHtDJLvx5
#PIDs #PersistentIdentifier #FDM #FAIR #OpenScience #OpenData #RDM #PIDNetwork
Since 2024, DataCite's Global Access Fund has supported 20 projects expanding equitable access to DataCite infrastructure. See how training, outreach, and infrastructure development in regions where PID adoption is still emerging are helping to build a more open, global community: https://doi.org/10.5438/29r5-rk13
@Mohamadmostafa
#DataCite
#GlobalAccessFund
#PersistentIdentifiers
#PIDs
#OpenInfrastructure
#OpenScience
#EquitableAccess
#PIDAdoption
#ScholarlyCommunication
#ResearchData
#FAIRData
#OpenPharma just published a vision statement calling on #pharma companies to make their research #OpenAccess.
https://bmjopen.bmj.com/content/16/5/e104128
The vision statement calls for OpenAccess to texts, #OpenData (under #FAIR principles), open #PIDS (#ORCID and #ROR), plain language summaries, and patient involvement.
It understands that the goal is a stretch. and distinguishes easier short-term goals from harder long-term goals, while arguing for both.
OpenPharma is funded by voluntary contributions from pharma companies, and considers itself a collaboration of "a number of important stakeholder groups: the pharmaceutical industry, publishers, patients, academics, regulators, editors, non-pharmaceutical funders and societies."
https://www.openpharma.blog/wp-content/uploads/2021/02/2020-01-15-Charter-of-Open-Pharma.pdf
Also see the OpenPharma home page.
https://www.openpharma.blog/
Open Science aims to fight misinformation and improve trust in scientific research; it encourages the reliability and accessibility of evidence, reduces inequalities through the democratisation of scientific knowledge and focuses scientific endeavours on issues of societal significance. As a multisponsor collaboration committed to driving positive change, Open Pharma has a multifaceted vision for scientific research publications funded by pharmaceutical companies (‘company research publications’) that aligns strongly with Open Science tenets. This new vision statement outlines our forward-looking principles for company research publications, both for short-term attainment (‘immediate’) and long-term commitment (‘ultimate’). Together, the principles provide a framework for positive collective action by all stakeholders involved in the development and dissemination of peer-reviewed company research publications. Underpinned by our central commitment to transparency for company research publications, we outline goals for: universal access to these publications; provision of peer-reviewed plain language summaries of the publications to aid comprehension among non-specialist readers; leveraging author and institutional metadata to advance transparency, discoverability and research impact; working towards FAIR (Findability, Accessibility, Interoperability, and Reuse) data principles through cross-sector consensus and action, and disclosure of patient involvement in research and its reporting to support transparency and encourage a research ecosystem attuned to patient centricity. We call on all stakeholders to realise the Open Pharma Vision and achieve an open and trusted future for company research publications that will ultimately advance patient care and improve global health.
DataCite welcomes 4 newly elected Board members:
Bessem Aamira, Véronique Stoll, José Benito González López, and Merilen Ivask-Oprelianska.
We also thank outgoing Board members for their years of service to DataCite’s mission & community.
Learn more about them on our blog: https://doi.org/10.5438/57p9-jm78
#DataCite #OpenScience #OpenResearch #ResearchInfrastructure #OpenInfrastructure #ScholarlyCommunication #PersistentIdentifiers #PIDs #DOI #CommunityGovernance #ResearchCommunity #BoardElections
We’re seeking community input on future additions to the DataCite Metadata Schema:
- a proposed new Access property: https://github.com/datacite/datacite-suggestions/discussions/235
- an updated definition for resourceTypeGeneral “Book”: https://github.com/datacite/datacite-suggestions/discussions/234
Please share your feedback by 12 May.🙌
#DataCite #Metadata #MetadataSchema #PersistentIdentifiers #PIDs #DOI #OpenScience #OpenResearch #ScholarlyCommunication #CommunityFeedback #FAIRData #ResearchInfrastructure #CommunityDriven #OpenInfrastructure
Heading to the #CoSector Festival of Technology in London on 5 May?
The research ecosystem is only as strong as its connections 🔗Look for ORCID's Shivendra Naidoo who will be on hand to talk #PIDs and #researchinfrastructure.
👉 More here:
https://www.cosector.com/festival/#ORCIDisEverywhere
Heading to the #CoSector Festival of Technology in London on 5 May?
The research ecosystem is only as strong as its connections 🔗Look for ORCID's Shivendra Naidoo who will be on hand to talk #PIDs and #researchinfrastructure.
👉 More here:
https://www.cosector.com/festival/#ORCIDisEverywhere
🚀 New Publication Alert! 🚀
We are excited to share our latest report: Report on Metadata & PID Workflows: Integration of Persistent Identifiers into ELN and DMP Tools for NFDI.
Key highlights:
✅ Results from our focus groups & Berlin workshop.
✅ Identification of PID integration pathways for instruments, samples, & projects.
✅ Foundation for our upcoming 2026 incubator projects with TS4NFDI.
Read the full report here:
🔗 https://doi.org/10.5281/zenodo.19607306
This report documents the PID Coordination Hub's coordinated effort to integrate persistent identifiers (PIDs) into the research data lifecycle through data management plans (DMPs) and electronic lab notebooks (ELNs). During 2025, the endeavor included establishing two focus groups. Each group held three virtual meetings from spring through summer, culminating in a joint in-person workshop in Berlin in September 2025. The report summarizes findings on metadata workflows, PID integration pathways, and technical interoperability requirements. These findings establish a foundation for two incubator projects that will launch in 2026 in collaboration with TS4NFDI. The projects aim to operationalize the DataCite metadata schema as a canonical reference model within the NFDI and demonstrate how capturing high-quality, standards-aligned metadata early on can enable seamless PID workflows across the research data lifecycle.
Steffi Genderjahn
PID Network Deutschland
DataCite
petersuber
ORCID Organization
PID4NFDI